Erythromycin shows promise in treatment of myotonic dystrophy type 1, study finds

A recent study published in eClinicalMedicine has shed light on the potential of erythromycin in the treatment of myotonic dystrophy type 1 (DM1). DM1 is a debilitating condition caused by a CTG repeat expansion in the DMPK gene, leading to…